Summary Chromosome 18 was analysed using a banding technique and fluorescence in situ hybridization (FISH) in 13 pancreatic carcinoma samples. The cytogenetic analysis revealed that chromosome 18 abnormalities were present in all cases and that several different rearrangements, such as translocations, deletions, dicentrics and ring chromosomes, were often found together. FISH mapping using 18q YAC probes showed that all tumours had lost at least one copy of 1 8q and that 1 8p was over-represented in 6 of the 13 cases. Furthermore, out of 13 identified deletion breakpoints on 18q, 11 were mapped to 18q11. The clustering of breaks close to the centromere indicates that loss of genes in bands 18q11 and 18q12, in addition to those located in 18q21, e.g. DPC4 and DCC, are important in the development of pancreatic tumours.
Although only a handful of larger series of cytogenetically investigated pancreatic carcinomas have been reported, several frequent recurrent chromosomal imbalances, such as trisomy 7 and 20, monosomy 18, loss of Ip, 3p, 6q, 8p, 9p, 17p and 19p , and gain of lq, 3q, 8q, 1 lq, 19q and 20q, have been identified (Johansson et al, 1992; Bardi et al, 1993; Griffin et al, 1994 Griffin et al, , 1995 Gorunova et al, 1998) . The pattern of cytogenetic imbalances seems characteristic for pancreatic cancer, albeit many of the individual changes are also found in other solid tumours (Mertens et al, 1997) . Loss of heterozygosity (LOH) studies have confirmed the cytogenetic features in pancreatic tumours as regards losses, showing a high incidence of allelic imbalance at lp, 3p, 9p, 13q, 17p and 18q Hahn et al, 1995; Shridhar et al, 1996) . In some of the frequently deleted regions, a concomitant inactivation of a tumour-suppressor gene (TSG) on the remaining normal chromosome has been shown, i.e. CDKN2A in 9p2l Bartsch et al, 1995) , BRCA2 in 13q12 (Goggins et al, 1996) , TP53 in 17pl3 (Ruggeri et al, 1992; Scarpa et al, 1993) and SMAD4 (DPC4) in 18q21 , whereas the TSGs in the other loci remain to be identified.
The most common chromosome aberration in pancreatic cancer is monosomy 18 (Johansson et al, 1992; Bardi et al, 1993; Griffin et al, 1994 Griffin et al, , 1995 . However, recent cytogenetic and comparative genomic hybridization (CGH) analyses (Mahlamaki et al, 1997) have also revealed frequent partial deletions of 18q. In the majority of the cases, the CGH data indicate breaks in 18cen-q2 1, leading to loss of the distal half of 18q (Mahlamaki et al, 1997) , including the genes DCC and SMAD4 (Fearon et al, 1990; Hahn et al, 1996) . As a large proportion of these breaks are located close to the centromere, in bands 18q 11-12 (Gorunova et al, 1998) , at quite a distance from DCC and SMAD4, larger deletions of 18q, including other putative TSGs, may be pathogenetically important in pancreatic carcinoma. However, cytogenetic and CGH breakpoint mapping of chromosome 18 is particularly difficult and may hence yield uncertain information. To investigate further such changes in pancreatic carcinoma and to map the extension of the 18q deletions with higher precision, we have applied fluorescence in situ hybridization (FISH), using a whole chromosome 18 paint (wcp) probe, a partial paint probe (pcp) for 18q and precisely mapped YAC clones.
MATERIALS AND METHODS

Patients
Thirteen tumour specimens were obtained from 12 patients with exocrine carcinoma of the pancreas, including one located in papilla Vateri, undergoing treatment at the Department of Surgery, Lund University Hospital, Sweden. For carcinomas unresectable at the time of diagnosis, i.e. when pancreatectomies could not be performed, the site of origin was based on pre-and perioperative examinations. Clinical data, including sex, age, morphology, grade and site, are given in Table 1 .
Cytogenetic analysis
The initial cytogenetic analyses, using G-banding, were performed on short-term, non-passaged cultures, as described in Gorunova et al (1995) . The cultures were passaged four to eight times for expansion and to free them from normal cells. Metaphase spreads for FISH analysis (see below) were then obtained. To exclude the possibility that the FISH studies were made on chromosomal rearrangements arising in vitro, all chromosome 18 abnormalities identified by FISH were compared with the initial karyotypes and only those seen in non-passaged cultures were considered in the FISH results. 
Probes and FISH analysis
The labelled wcpl8 probe was purchased from Cambio (Cambridge, UK). The pcpl8q was obtained from CP Li Biomedical Research (Arlington, USA). The following chromosome 18 YACs, obtained from CEPH, were used: 694b3, 820c6, 766f9, 937hl2, 739a3 (SMAD2), 745bll (SMAD4), 955c2 and 961hl2. The YAC 4ODH1, spanning the DCC locus, was kindly provided by Dr G Silverman. The approximate chromosomal location of the YAC markers is given in Figure 2 . The YAC map given on the right side of the ideogram is based on the map published by Giacalone et al (1996) , except for 955c2 (Bray-Ward et al, 1996) . YAC probe preparations were performed as in Lengauer et al (1992) , using Alu primers described in Hoglund et al (1998) . Probes were labelled with either biotin or digoxygenin-conjugated dUTP, using Amersham's Mega Prime kit (Amersham, UK). After labelling, the DNA was purified on a Sepharose CL-6B column (Pharmacia, Uppsala, Sweden). The FISH analyses were performed essentially as described in Hoglund et al (1998) . The hybridization signals were analysed in a CytoVision Ultra system (Applied Imaging, Sunderland, UK), using a charged coupled device (CCD) camera. After an initial screen of 20-30 metaphases, 10-20 per probe were analysed in detail.
RESULTS
The cytogenetic and FISH results regarding chromosome 18 are summarized in Table 1 and Figures 1-3.
LPC1 p
The cytogenetic analysis showed the presence of two add(18)(ql2) and two del(18)(q21). The add(18) was negative for the most proximal marker on the q arm, but positive for the pcpl8q, indicating a break in 18q1 1. The del(l8) was found to have a break between the 739a3 and the 745b1 1 YAC probes, corroborating the 18q21 breakpoint. In addition, the FISH analysis disclosed two derivative chromosomes containing the 745bl1-955c2 YACs, and these derivatives were later cytogenetically reinterpreted as der(7)t(7;18) (qll ;q21). As this tumour was triploid, one copy of 18qI1-qter was lost, whereas one copy of 18pter-cen-18q1 1 was gained.
LPC2p
The cytogenetic investigation of this triploid tumour revealed the presence of two normal chromosomes 18. The wcpl8 probe also detected one ring chromosome. The ring contained one segment of 18q origin, as determined by the pcpl8q. This ring chromosome had cytogenetically been interpreted as a der(6)r(6)(p25q21)ins (6;?)(ql3;?). A proportion of the cells did not contain the ring but a large chromosome, ins(6;?)(ql3;?), with two to three segments of 18q origin. None of the 18q21 probes hybridized to these segments. Hence, one copy of chromosome 18 was lost except for the short unidentified 18q regions present in the ring and ins(6;?) chromosomes.
LPC3p
The cytogenetic analysis revealed two copies of a der (18) Chromosome 18 aberrations in pancreatic cancer 1897
18p YACs hybridized to both arms of the add(l 8), indicating the presence of a possible isochromosome of 18p. The cytogenetic reanalysis, however, showed that the arms were not symmetrical, suggesting that the add( 18) was in fact a der( 1 8)t( 18; 18)(pl 1 ;q 11).
As this tumour was triploid, two copies of 18q were lost and two copies of 18p were gained.
LPC9p
The cytogenetic analysis showed, in addition to one normal chromosome 18, an i(18)(plO), alternatively a del (18)(q12), and an add(l8)(q 1). The FISH analysis, using wcpl8, all 18q YACs and the pcp 18q, revealed one normal chromosome 18 and two different add(18)(qll). Thus, two copies of 18qll-qter were lost in this triploid tumour. (22) as regards the presence of 18q material. Two other chromosomes were shown to contain chromosome 18 material using FISH. One of these (ml, Figures 2 and 4A ) had one interstitial and one terminal segment of 18p origin. The interstitial segment was positive for both the 18p YACs, whereas the terminal segment was negative for both these probes. The second chromosome, cytogenetically identified as der(11)t(11; 11)(p 14;q 13), contained one interstitial segment of 18q that was negative for the 18q21 YACs. Thus, this tumour had lost one copy of 18q1 l-qter, two copies of 18pter-cen-q 11 and one copy of 18cen-q 11.
LPC1 Om
The cytogenetic analysis revealed an idic( 1 8)(q 11) and one normal chromosome 18. The FISH analysis also identified one metacentric and one smaller marker with chromosome 18 material ( Figure   4B ). The metacentric marker had 18p material on one of the arms, positive for both 18p YACs. The smaller marker was positive for the 18p YACs and had a break in the centromere, or very close to it. The idic(18) chromosome arms hybridized to the wcp 18, whereas the central segment was positive for pcpl8q. Further hybridizations with the 18p YACs verified the idic(18). The central segment was negative for YAC 766f9, the most proximal marker on the q arm. Thus, this triploid tumour had lost two copies of 18q I1 -qter and gained two copies of 18p.
LPC11 p and LPC11 m
The cytogenetic analysis of both the primary tumour and its metastasis revealed three to four copies of add(18)(ql2). The FISH analysis, however, disclosed a second derivative 18, in two copies, with a large insertion in 18p, and YAC hybridizations showed that the insertion point was between 694b3 and the telomere. Cytogenetically, this insertion was identified as an ins(l8;X)(pll;q21q28). One more derivative, der(l8), was positive for pcp 18q and the two 18p YACs but negative for 766f9. The add(18)(ql2) was positive for the 766f9 and 937h12 probes but negative for the 18q21-22 markers. In the LPC 1lp, the add(l8)(q12), ins(18;X) and der(l8) were present in four, two and one copy respectively. The two former abnormalities were found in three and two copies in LPC 11 m, whereas the der(18) was only seen occasionally in the metastasis. As both LPC 11 p and LPC 11 m were tetraploid, the former had lost two copies of 18q 12-qter and gained two copies of 18pter-cen-q 12 and one copy of 18pter-cen-q 11, whereas the latter sample had lost two copies of 18q12-qter and gained one copy of 18pter-cen-q 12. LPC7m
Only one copy of chromosome 18 was present, as shown by both cytogenetics and FISH. Thus, one chromosome 18 was lost in this diploid tumour.
LPC8p
By cytogenetic means two add(18)(q 12) and one normal chromosome 18 were detected. The FISH analysis revealed that the
LPC1 2m
The cytogenetic analysis showed one dic(l8;2 1)(q 1 l;p12) and one normal chromosome 18. The FISH analysis also disclosed two markers with small segments of 18q material, identified only with the pcp 1 8q. The dic(18;2 1) was negative for the 766f9 probe but positive for pcpl 8q, indicating a break in 18q 11. On balance, this triploid tumour had lost one chromosome 18 and one copy of 18ql l-qter.
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In summary, the combined cytogenetic and FISH results revealed loss of 18q material, consistently including 18ql2-qter, in all tumours. Out of 13 identified breaks resulting in deletion of 18q, 11 occurred in 18q 11. Over-representation of 18p was detected in six samples, always including the entire arm.
DISCUSSION
The present results showing gain of 18p in almost half of the pancreatic carcinoma samples analysed (6 out of 13) agree well with the previous CGH studies of Solinas-Toldo et al (1996) , Fukushige et al (1997) and Mahlamaki et al (1997) , revealing 18p over-representation in 4 of 23, 8 of 18 and 5 of 18 informative cases respectively. Neither in the present series nor in the previous CGH studies were partial duplications of 18p seen, i.e. no specific l8p region can, as yet, be delineated as the target for the detected over-representation. Gains of 18p have also been described in transitional cell carcinoma of the bladder, with a distinct amplification of 18pl 1 (Voorter et al, 1995) . The oncogene YES, a SRC-related membrane-bound tyrosine kinase, is located within this band (Silverman et al, 1993) and has been found to be overexpressed in both melanoma (Loganzo et al, 1993) and colon carcinoma (Park et al, 1993) . It is possible that over-representation of 18p may increase the expression of genes on this arm, such as YES, of possible pathogenic importance in pancreatic carcinogenesis. In four of the present cases (LPC2p, LPC6p, LPC7m and LPC 12m), 18p material was lost. In three of these, however, the 18p deletions occurred through loss of one entire chromosome 18, and it is likely that the concomitant 18q deletion was the pathogenetically important change in these cases.
All 13 samples investigated showed under-representation of 18q material -as loss of chromosome 18 in three cases, complete loss of 18q in three cases and partial deletions of 18q in seven cases. None of the tumours displayed a total absence of a tested YAC marker, i.e. nullisomy for 18q material was not seen. The observed frequent loss of 18q is in agreement with earlier cytogenetic (Johansson et al, 1992; Bardi et al, 1993; Griffin et al, 1994 Griffin et al, , 1995 , CGH (Fukushige et al, 1997; Mahlamaki et al, 1997) and LOH studies (Hahn et al, 1995) . In the ten cases in which losses of 18q occurred through breaks in the q arm, the breakpoints were localized using both YAC and pcpl8q probes. Of the recorded 13 breaks in 18q, 11 were mapped to 18q 11. The fact that the breakpoints clustered to at least two different subregions within this band, 18q 11.1 and 18q 11.2 (Figure 3) , argues against the presence of a preferentially break-prone region induced by a local change in the chromatin, as has been suggested for the frequent breaks in 3pl4 in pancreatic carcinoma (Shridhar et al, 1996) . Furthermore, the clustering of breaks close to the centromere indicates that loss of genes in bands 18q 11 and 18q1 2 are important in the development of pancreatic tumours.
SMAD4 and DCC are located in 18q21 and both these genes have been implicated in pancreatic tumorigenesis (Hohne et al, 1992; Simon et al, 1994; Hahn et al, 1996) . However, no inactivating mutations in DCC have been reported in pancreatic cancer, and the importance of this gene in neoplasia has recently been questioned (Fazeli et al, 1997) . SMAD4, on the other hand, has been shown to be functionally inactivated in a large proportion of pancreatic carcinomas . However, SMAD4 is only mutated in 22% of the cases showing LOH at this locus , indicating that this gene may not always be the target for 18q deletions. The closely linked SMAD2, which shows a great sequence similarity to SMAD4 and also functions as part of the transforming growth factor beta (TGFB) signal transducing pathway (Eppert et al, 1996) , may, in analogy with SMAD4, function as a tumour-suppressor gene, although no SMAD2 mutations in pancreatic carcinomas have been reported as yet. Taking into account the high frequency, 90-100%, of 18q deletions reported in pancreatic tumours (Hahn et al, 1995; Gorunova et al, 1998 ; this report), the relatively low incidence of functional abrogation of SMAD4 in cases with LOH at this locus, and the present identification of proximal 1 8q deletion breakpoints, it seems reasonable to suggest the presence of an additional TSG on 1 8q of importance in pancreatic carcinomas. In favour of yet another TSG on 18q are recent molecular genetic findings in colon and lung carcinomas. Colon cancers show a similar deletion profile of 1 8q, with frequent breaks in 18qll-12, as pancreatic carcinoma, but with few concomitant inactivating mutations of SMAD4 or SMAD2 (Thiagalingam et al, 1996) . Similarly, in lung cancer, which shows LOH at 18q21 in 30-60% , functional loss of SMAD4 or SMAD2 is very rare Uchida et al, 1996) . Furthermore, mutations of SMAD4 and SMAD2 are rarely seen in other tumours, such as carcinomas of the oesophagus, stomach, bladder, prostate and breast showing LOH at 18q21 (Barrett et al, 1996; Lei et al, 1996; Schutte et al, 1996) . We thus conclude that 18q harbours at least one more proximally located TSG, which is shared among various tumour types, including pancreatic tumours, with 1 8q deletions, and one, SMAD4, that may be specific for pancreatic cancer.
